KIRSTEN DAVIS: Open Payments
NPI 1174083919 · BARBERTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$660 in 17 payments from 13 companies in 2025. Trend: 2023 $243 · 2024 $381 · 2025 $660
Food & beverage: $660
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $154 |
| GlaxoSmithKline, LLC. | 2 | $136 |
| Exelixis Inc. | 1 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $54 |
| Inspire Medical Systems, Inc. | 1 | $35 |
| Janssen Biotech, Inc. | 1 | $31 |
| Daiichi Sankyo Inc. | 1 | $30 |
| Invivyd Inc | 1 | $24 |
| Genmab U.S., Inc. | 1 | $22 |
| Exact Sciences Corporation | 1 | $21 |
Products named: Ozempic, AREXVY, CABOMETYX, INSPIRE, TALVEY, Enhertu, FRUZAQLA, VPRIV.
Industry payments across OH — which companies pay providers there.
